内容提示: Indian Accounting Standard (Ind AS) 36 Impairment of AssetsContents ParagraphsObjective 1Scope 2–5Definitions 6Identifying an asset that may be impaired 7–17Measuring recoverable amount 18–57Measuring the recoverable amount of an intangible asset with an indefinite useful life 24Fair ...
therapeutic indication, and scope of the proposed clinical trial. In principle, the duration of the animal toxicity studies conducted in two mammalian species (one nonrodent) should be equal to or exceed the duration of ...
While the Indian Trust Act, 1882 does not mandate the creation of a trust deed, it is recommended that a trust deed be entered into to identify the scope of rights / obligations of trustees, the assets of the trust as well as beneficiaries. Accordingly, it is recommended that the trust d...
Prior to this approval, the IASO-782 Injection has received IND approval in both China and the U.S. for the treatment of immune thrombocytopenic purpura (ITP) and warm autoimmune hemolytic anemia (wAIHA). The latest approval for the indication of SLE further expands the therapeutic scope of th...
Cancel Submit feedback Saved searches Use saved searches to filter your results more quickly Cancel Create saved search Sign in Sign up Reseting focus {{ message }} mideind / GreynirServer Public Notifications You must be signed in to change notification settings Fork 17 S...
Data delayed at least 15 minutes, as of Dec 12 2024 10:12 GMT. Find More Stocks Use our equities screener to discover other potential opportunities. Go to the Equities Screener Your alerts About the company The Supreme Industries Limited is a plastic products manufacturing company. The Company ...
TNI was elevated over 0.1 ng/ml (risk stratification cut-off for ) in 4 patients before and in 12 patients after EPS. There was no relationship between LV-EF, CHD, and the elevation of TNI after the EPS.: TNI can be elevated by (induced) tachycardias within the scope of ...
marketing application NDA can be submitted. In order to be approved for marketing; after the listing, the development company still needs to conduct phase IV clinical research and post-marketing monitoring of the product, so that it can fully understand the mechanism, scope, therapeutic effect, ...
(laboratory animals or in vitro) studies on the basis of which the sponsor of the IND application has concluded that it is reasonably safe to conduct the proposed clinical investigations. The kind, duration, and scope of animal and other studies required in the application will depend on the ...
and diversifying service offerings. Why traditional CDMOs are broadening their scope by taking on development roles alongside manufacturing, reshaping their role within the pharmaceutical supply chain. Assessing the impact of larger pharmaceutical companies entering the CDMO sector, and the resultant shifts...